Nichols William Garrett
Chief Medical Officer at CADL; Chief Medical Officer at CHIMERIX INC
- Sold, on record
- $849k
- Dollars the filings state
- Form 4 sales
- 10
- Latest Jul 28, 2025
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- CADLCandel Therapeutics, Inc.Chief Medical Officer
- CHIMERIX INCChief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CADL102,840 shares
- CHIMERIX INC42,035 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale CADLNo planJul 17 2024
Sold 10,875 shares at $6.47 ($70k)
Nichols William Garrett, Chief Medical Officer
No 10b5-1 planSold 8.7% of holdings ($811k position)114,482 shares leftFiling
- 2 Form 144 notice CADLNoticeNov 29 +135 days
Filed to sell 12,675 shares ($63k)
Nichols William Garrett, Officer
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale CADLNo planNov 29 same day
Sold 13,935 shares at $4.56 ($63k)
Nichols William Garrett, Chief Medical Officer
No 10b5-1 planSold 12.2% of holdings ($522k position)100,547 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 4 sale CADLNo planJan 8 +40 days
Sold 10,799 shares at $8.22 ($89k)
Nichols William Garrett, Chief Medical Officer
No 10b5-1 planSold 10.7% of holdings ($826k position)89,748 shares left1x usual sizeFiling
- 5 Form 4 sale CADLNo planJan 15 +7 days
Sold 10,428 shares at $7.23 ($75k)
Nichols William Garrett, Chief Medical Officer
No 10b5-1 planSold 11.6% of holdings ($649k position)79,320 shares left1x usual sizeFiling
- 6 Form 4 sale CADLUnusualMar 18 +62 days
Sold 45,316 shares at $8.76 ($397k)
Nichols William Garrett, Chief Medical Officer
10b5-1 planSold 46.3% of holdings ($857k position)52,493 shares left4.2x usual sizeFiling
- 7 Form 4 sale CADLRoutineJun 30 +104 days
Sold 781 shares at $5.04 ($4k)
Nichols William Garrett, Chief Medical Officer
10b5-1 planSold 1.5% of holdings ($269k position)52,493 shares left0.1x usual sizeFiling
- 8 Form 4 sale CADLRoutineJul 28 +28 days
Sold 937 shares at $6.98 ($7k)
Nichols William Garrett, Chief Medical Officer
10b5-1 planSold 1.8% of holdings ($373k position)52,493 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2025 | CADL | Chief Medical Officer | Form 4 sale | 937 | $7k | 1.8% | Routine | SEC |
| Jun 30, 2025 | CADL | Chief Medical Officer | Form 4 sale | 781 | $4k | 1.5% | Routine | SEC |
| Mar 18, 2025 | CADL | Chief Medical Officer | Form 4 sale | 45,316 | $397k | 46.3% | Unusual | SEC |
| Jan 15, 2025 | CADL | Chief Medical Officer | Form 4 sale | 10,428 | $75k | 11.6% | No plan | SEC |
| Jan 8, 2025 | CADL | Chief Medical Officer | Form 4 sale | 10,799 | $89k | 10.7% | No plan | SEC |
| Nov 29, 2024 | CADL | Chief Medical Officer | Form 4 sale | 13,935 | $63k | 12.2% | No plan | SEC |
| Nov 29, 2024 | CADL | Officer | Form 144 notice | 12,675 | $63k | Notice | SEC | |
| Jul 17, 2024 | CADL | Chief Medical Officer | Form 4 sale | 10,875 | $70k | 8.7% | No plan | SEC |
| Jul 11, 2024 | CADL | Chief Medical Officer | Form 4 sale | 9,769 | $58k | 7.2% | No plan | SEC |
| Feb 10, 2020 | CHIMERIX INC | Chief Medical Officer | Form 4 sale | 11,355 | $19k | 4.2% | Plan not stated | SEC |
| Jan 7, 2020 | CHIMERIX INC | Chief Medical Officer | Form 4 sale | 30,680 | $66k | 10.2% | Plan not stated | SEC |